357338-13-7 Usage
Uses
Used in Pharmaceutical Research:
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide is used as a research compound for exploring its diverse biological activities, including anti-inflammatory, antibacterial, and antifungal properties. Its unique structure and chiral configuration contribute to its potential applications in drug development and medicinal chemistry.
Used in Drug Development:
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide is used as a starting material or intermediate in the synthesis of new pharmaceutical compounds. Its potential biological activities and chiral nature make it a valuable component in the development of innovative drugs targeting various diseases and conditions.
Used in Medicinal Chemistry:
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide is used as a key building block in the design and synthesis of novel therapeutic agents. Its unique structural features and chiral configuration allow for the creation of enantiomerically pure compounds with improved pharmacological properties and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 357338-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,7,3,3 and 8 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 357338-13:
(8*3)+(7*5)+(6*7)+(5*3)+(4*3)+(3*8)+(2*1)+(1*3)=157
157 % 10 = 7
So 357338-13-7 is a valid CAS Registry Number.
357338-13-7Relevant academic research and scientific papers
Formal synthesis of brivaracetam: A key to construct the pyrrolidone scaffold using Pd-catalyzed oxidative cyclization and ring-closing metathesis reaction
Chavan, Subhash P.,Kawale, Sanket A.,Chavan, Prakash N.
supporting information, (2019/11/11)
A short and efficient synthetic approach for brivaracetam has been accomplished via two different routes which utilize Pd-catalyzed oxidative cyclization and ring-closing metathesis (RCM) as the key reaction. These two routes are novel, simple, scalable and rely on (E)-pent-2-en-1-ol and valeraldehyde as a commercially available starting material to yield brivaracetam with good overall yield.
PROCESS FOR PREPARING BRIVARACETAM
-
Page/Page column 7-8, (2017/06/23)
The present invention relates to a new process for preparing brivaracetam. (Ib)
CONTINUOUS PROCESS FOR PREPARING BRIVARACETAM
-
Page/Page column 10, (2017/09/02)
The present invention relates to a continuous flow process for preparing brivaracetam.
NEW HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS
-
Page/Page column 61-62, (2008/12/08)
The present invention relates to new compounds, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
